Achieve Life Sciences (STU:SP4P) Total Stockholders Equity : €45.50 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Achieve Life Sciences Total Stockholders Equity?

Achieve Life Sciences's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €45.50 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Achieve Life Sciences's Book Value per Share for the quarter that ended in Mar. 2024 was €1.33. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Achieve Life Sciences's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.35.

Achieve Life Sciences Total Stockholders Equity Historical Data

The historical data trend for Achieve Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences Total Stockholders Equity Chart

Achieve Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

16.25

30.65

24.82

7.84

-1.33

Achieve Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															0.41	8.95	3.78	-1.33	45.50

Achieve Life Sciences (STU:SP4P) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Achieve Life Sciences's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(45.5	-	0)	/	34.2519
	=	1.33

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Achieve Life Sciences's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(15.818	+	0)	/	45.5
	=	0.35

Achieve Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Achieve Life Sciences (STU:SP4P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (STU:SP4P) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ACHV:USA SP4P:Germany

Address

22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021

Website

https://www.achievelifesciences.com

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.

Achieve Life Sciences (STU:SP4P) Headlines

No Headlines